Grail, Inc. (NASDAQ:GRAL – Get Free Report) CEO Robert P. Ragusa sold 123,454 shares of Grail stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $14.02, for a total value of $1,730,825.08. Following the sale, the chief executive officer now owns 612,661 shares in the company, valued at $8,589,507.22. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Grail Stock Performance
NASDAQ:GRAL opened at $14.76 on Friday. Grail, Inc. has a one year low of $12.33 and a one year high of $23.36. The business’s 50-day simple moving average is $14.19.
Grail (NASDAQ:GRAL – Get Free Report) last posted its quarterly earnings results on Tuesday, August 13th. The company reported ($5.30) earnings per share for the quarter. The company had revenue of $31.97 million during the quarter.
Wall Street Analysts Forecast Growth
View Our Latest Stock Analysis on Grail
About Grail
GRAIL, Inc, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.
Further Reading
- Five stocks we like better than Grail
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Survey Reveals: America’s Most Coveted Businesses in 2024
- Dividend Capture Strategy: What You Need to Know
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- How Technical Indicators Can Help You Find Oversold Stocks
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.